Skip to content

J&J Corporate Biomaterials Center

Country not established

Devices
1

What J&J Corporate Biomaterials Center makes

The company produces absorbable foam buttresses, which are temporary surgical implants used to reinforce vascular anastomoses during procedures like coronary artery bypass grafting.

These devices are classified as Class II under FDA regulations and are listed via the 510(k) pathway. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

Frequently asked questions

How many devices does J&J Corporate Biomaterials Center have in the registry?

The registry currently lists 1 device for J&J Corporate Biomaterials Center. Devices recorded under merged duplicate company entries are counted once.

Which registries list J&J Corporate Biomaterials Center's devices?

Among its 1 most recently registered device, J&J Corporate Biomaterials Center has devices listed in FDA 510(k) (1 device).

What risk classes do J&J Corporate Biomaterials Center's devices fall under?

Among its 1 most recently registered device, the classes recorded for J&J Corporate Biomaterials Center's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from J&J Corporate Biomaterials Center in the registry?

The most recently registered devices listed for J&J Corporate Biomaterials Center include AFB (ABSORBABLE FOAM BUTTRESS).

Generated automatically from registry data and not verified by a human reviewer.